Undisclosed Novel Small Molecule Programs

About Vivreon Biosciences

Vivreon Biosciences is a preclinical biotech company targeting novel mechanisms in inflammation to serve patient populations unresponsive to current treatments. The company possesses integrated in-house capabilities, including a wet lab and an AAALAC-accredited vivarium, supporting its drug discovery and early development efforts. As a private, pre-revenue entity, Vivreon's success hinges on advancing its pipeline candidates into clinical trials and securing strategic partnerships or funding.

Therapeutic Areas